Results of early treatment for de novo donor‐specific antibodies in pediatric kidney transplant recipients in a cross‐sectional and longitudinal cohort

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3046|22|2|petr.13108-petr.13108

ISSN： 1397-3142

Source： PEDIATRIC TRANSPLANTATION, Vol.22, Iss.2, 2018-03, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early immunosuppression treatment correlates with later de novo donor‐specific antibody development after kidney and pancreas transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 12, 2015-12 ,pp. : 1119-1127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor‐Specific Antibody

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 11, 2015-11 ,pp. : 2921-2930

John Wiley & Sons Inc

Access to resources Recommend Favorite

De novo donor‐specific anti‐HLA antibodies mediated rejection in liver‐transplant patients

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 12, 2015-12 ,pp. : 1371-1382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Donor‐specific anti‐HLA antibodies in pediatric renal transplant recipients with creeping creatinine: Prevalence, histological correlations, and impact on patient and graft survival

By  

PEDIATRIC TRANSPLANTATION, Vol. 1397-3142, Iss. 7, 2015-11 ,pp. : 684-690

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development and Impact of De Novo Anti‐HLA Antibodies in Pediatric Heart Transplant Recipients

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 8, 2015-08 ,pp. : 2215-2222

John Wiley & Sons Inc

Access to resources Recommend Favorite